Orchid Chemicals Unveiling 3 Products In US This Year

Chennai: Orchid Chemicals & Pharmaceuticals will unveil three drugs in the US market this year. The company hopes a 25 per cent jump in its revenues for the current year. The three drugs are: Cefepime and Cefdinir in the Cephalosporin range and Tazobactum-Piperaillin in the penicillin range. Giving a calendar for growth. In 2008-09, Orchid would launch a few antibiotic drugs in the carbopenam range. The company has about a dozen products in that range. The year 2009-10 would see another step function jump because of unveil of another clutch of carbopenams and a range of non-antibiotic products in the US. Further in 2009-10, Orchid would foray the Japanese market. Meanwhile, the anti-diabetes drug that Orchid has been trying to bring in has suffered further delay. Orchid is working on one new drug for cancer and another for inflammation.